Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Roper

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|August 20, 2015
Conflicts of InterestNitin Roper
Journal of General Internal Medicine|May 28, 2015
Industry Collaboration and Primary Guest Authorship of High-Impact Clinical TrialsNitin Roper, Deborah Korenstein
Journal of General Internal Medicine|April 3, 2015
Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional StudyNitin Roper, Deborah Korenstein
JAMA Internal Medicine|August 27, 2014
Industry collaboration and randomized clinical trial design and outcomesNitin Roper, Nasen Zhang, Deborah Korenstein
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testingNitin Roper, Barry Storer, Robert Bona, et al.
Clinical Epigenetics|June 19, 2012
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategiesJohn Mascarenhas, Nitin Roper, Pratima Chaurasia, et al.
Cancer Treatment Reviews|April 13, 2015
The landscape of precision cancer medicine clinical trials in the United StatesNitin Roper, Kristian D Stensland, Ryan Hendricks, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Impact of industry collaboration on randomised controlled trials in oncologyAnne Linker, Annie Yang, Nitin Roper, et al.
Annals of Medicine and Surgery (2012)|June 26, 2023
Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental researchAnthony B Cardillo, Sierra Kovar, Nitin Roper, et al.
American Journal of Hematology|August 24, 2010
An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myelomaNitin Roper, Daniel J DeAngelo, Frank Kuo, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|August 20, 2015
Conflicts of InterestNitin Roper
Journal of General Internal Medicine|May 28, 2015
Industry Collaboration and Primary Guest Authorship of High-Impact Clinical TrialsNitin Roper, Deborah Korenstein
Journal of General Internal Medicine|April 3, 2015
Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional StudyNitin Roper, Deborah Korenstein
JAMA Internal Medicine|August 27, 2014
Industry collaboration and randomized clinical trial design and outcomesNitin Roper, Nasen Zhang, Deborah Korenstein
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testingNitin Roper, Barry Storer, Robert Bona, et al.
Clinical Epigenetics|June 19, 2012
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategiesJohn Mascarenhas, Nitin Roper, Pratima Chaurasia, et al.
Cancer Treatment Reviews|April 13, 2015
The landscape of precision cancer medicine clinical trials in the United StatesNitin Roper, Kristian D Stensland, Ryan Hendricks, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Impact of industry collaboration on randomised controlled trials in oncologyAnne Linker, Annie Yang, Nitin Roper, et al.
Annals of Medicine and Surgery (2012)|June 26, 2023
Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental researchAnthony B Cardillo, Sierra Kovar, Nitin Roper, et al.
American Journal of Hematology|August 24, 2010
An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myelomaNitin Roper, Daniel J DeAngelo, Frank Kuo, et al.
Pageof 5